MedPath

Acute Effects of Dairy and Meat Proteins on Bone Metabolism and Metabolic Profile

Not Applicable
Completed
Conditions
Bone Metabolism
Obesity
Interventions
Other: Dietary meal intervention
Registration Number
NCT01773304
Lead Sponsor
University of Copenhagen
Brief Summary

The purpose of this randomized, controlled, cross over single meal study is to investigate the metabolic effects of a breakfast rich in dairy proteins and to determine biomarkers for their intake. The results from this project will increase our knowledge about nutritional value of dairy proteins, which is necessary to decide whether dairy products can be recommended for prevention of weight related bone loss.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
17
Inclusion Criteria
  • Healthy males and females between 18 and 50 years
  • BMI 25-40
Exclusion Criteria
  • Physical activity more than 10 hours weekly
  • Smoking
  • Diagnosed osteoporosis in at least one parent
  • Dietary supplements and vitamin pills (during the study and 2 months before the start)
  • Vegetarians and vegans
  • Lactose intolerant
  • Women who are pregnant, breastfeeding or post-menstrual
  • Regular intake of medication
  • Chronic diseases (including osteoporosis, cancer, diabetes, cardiovascular disease and mental disorders)
  • Participation in other clinical trials that could affect the test results
  • Donation of blod within 3 months before intervention start
  • Hypersensitivity to paraaminobenzoic acid (PABA)
  • Not able to comply with the procedures established by the Protocol

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Meal rich in meat proteinDietary meal intervention-
Meal rich in dairy proteinDietary meal intervention-
Primary Outcome Measures
NameTimeMethod
urine C-terminal carboxy-terminal collagenbaseline 24-h urine samples and 24-h urine samples after the meal test at both visits
serum osteocalcin (sOC)at 0, 30, 60, 120, 180 and 240 min at both visits
serum tartrate-resistant acid phosphatase (s-TRAP)at 0, 30, 60, 120, 180 and 240 min at both visits
urine deoxypyridinoline crosslink (uDPD)baseline 24-h urine samples and 24-h urine samples after the meal test at both visits
serum C-terminal carboxy-terminal collagen crosslinks (CTX)at 0, 30, 60, 120, 180 and 240 min at both visits
plasma metabolites for metabolomics analysesat 0, 30, 60, 120, 180 and 240 min at both visits
urine metabolites for metabolomics analysesbaseline 24-h urine samples, 24-h urine samples after the meal test, urine samples at 2-h and 4-h after the meal test and urine samples from 4-h to 24-h, all at both visits
Secondary Outcome Measures
NameTimeMethod
serum insulin-growth factor-1 (IGF-1)at 0, 30, 60, 120, 180 and 240 min at both visits
serum insulin-growth factor binding-protein-3 (IGFBP-3)at 0, 30, 60, 120, 180 and 240 min at both visits
serum glucoseat 0, 30, 60, 120, 180 and 240 min at both visits
serum insulinat 0, 30, 60, 120, 180 and 240 min at both visits
serum glukagon-like peptide-1 (GLP-1)at 0, 30, 60, 120, 180 and 240 min at both visits
urinary PABAbaseline 24-h urine samples and 24-h urine samples after the meal test at both visits
urinary creatininbaseline 24-h urine samples and 24-h urine samples after the meal test at both visits
urinary biobankbaseline 24-h urine samples and 24-h urine samples after the meal test at both visits
plasma biobankat 0, 30, 60, 90, 120, 180 and 240 min at both visits

Trial Locations

Locations (1)

Department of Human Nutrition, University of Copenhagen

🇩🇰

Copenhagen, Frederiksberg C, Denmark

© Copyright 2025. All Rights Reserved by MedPath